Atorvastatin regulates pericardial patch healing via the microRNA140-ADAM10-ephrinB2 pathway.

Xin Li, Alan Dardik, Ren Guo, Weichang Zhang, Yuanyuan Xiang, Shuang Li, Dingxiao Liu, Chang Shu

Open access · greenAbstract read

In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 45% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2.Medical science monitor : international medical journal of experimental and clinical research · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xin LiDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University Changsha 410011, Hunan, PR China.

Alan DardikDepartment of Surgery and The Interdepartmental Program in Vascular Biology & Therapeutics, Yale University School of Medicine New Haven, Connecticut, United States of America.

Ren GuoDepartment of Pharmacy, The Third Xiangya Hospital, Central South University Changsha 410013, Hunan, P R China.

Weichang ZhangDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University Changsha 410011, Hunan, PR China.

Yuanyuan XiangDepartment of Pharmacy, The Third Xiangya Hospital, Central South University Changsha 410013, Hunan, P R China.

Shuang LiDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University Changsha 410011, Hunan, PR China.

Dingxiao LiuDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University Changsha 410011, Hunan, PR China.

Chang ShuDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University Changsha 410011, Hunan, PR China.

Central South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADAM10atorvastatinendothelial progenitor cellsephrinB2microRNA-140Pericardial patch

Identifiers

PMID30662650

PMCPMC6325491

OpenAlexW2993721868

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.